Asahi Intecc to acquire RetroVascular for $26 million

Asahi Intecc's board agreed to acquire RetroVascular, a developer of cardiological tools for PTCA procedures, for approximately $25.9 million.

“Asahi Intecc said it will look for ways to incorporate the plasma energy technologies into its own devices, with hopes that it will be able to expand into fields outside cardiovascular use.”massdevice.com

• 1 source
• massdevice.comAsahi Intecc to buy RetroVascular for $26m - MassDeviceFink DensfordJul 12, 2018

Summarized from public sources; check the original articles before acting on it.